Federal contract award
75F40121P00610
THE OBJECTIVE OF THIS TRAINING IS TO ENSURE THAT ALL CVM STAFF ARE TRAINED TO PROVIDE PROFESSIONAL AND EFFECTIVE COMMUNICATION, WHICH ADHERES TO THE PLAIN LANGUAGE WRITING PRINCIPLES ESTABLISHED BY THE FDA. THE TECHNICAL WRITING AND PRACTICAL GRA
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 611430 — Professional and Management Development Training |
| PSC | U001 — Lectures For Training |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $67.5K |
| Current contract value | $67.5K |
| Potential contract value / ceiling | $67.5K |
| Start date | Sep 17, 2021 |
| Current end date | Apr 24, 2025 |
| Potential end date | Apr 24, 2025 |
| Latest award activity | Oct 21, 2025 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Oct 21, 2025 | P00006 | $-24.0K | THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS, CANCEL NON-FUNDED ITEMS 3, 8, 9, AND CLOSE OUT THE CONTRACT. |
| Apr 24, 2025 | P00005 | $0 | THE OBJECTIVE OF THIS TRAINING IS TO ENSURE THAT ALL CVM STAFF ARE TRAINED TO PROVIDE PROFESSIONAL AND EFFECTIVE COMMUNICATION, WHICH ADHERES TO THE PLAIN LANGUAGE WRITING PRINCIPLES ESTABLISHED BY THE FDA. THE TECHNICAL WRITING AND PRACTICAL GRAM |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Alice I. Mihill | Contact | Alice.Mihill@fda.hhs.gov 301-796-3247 | Source | Aug 20, 2021 |
| Anthony S. Wimbush | Contact | Anthony.Wimbush@fda.hhs.gov 240-402-7628 | Source | Aug 20, 2021 |
| Alice I. Mihill | Contact | Alice.Mihill@fda.hhs.gov 301-796-3247 | Source | Aug 14, 2021 |
| Anthony S. Wimbush | Contact | Anthony.Wimbush@fda.hhs.gov 240-402-7628 | Source | Aug 14, 2021 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.